Table 2. Correlations between CRs of the SNpc on NM-MRI and SUVRs of the striatum on 18F-FP-CIT PET on the clinically more affected side.
| Anterior putamen | Posterior putamen | Anterior caudate nucleus | Posterior caudate nucleus | Ventral striatum | ||
|---|---|---|---|---|---|---|
| More-affected N1 | ||||||
| Correlation | 0.319 | 0.464 | 0.057 | 0.029 | 0.024 | |
| Significance | 0.027* | 0.001* | 0.701 | 0.843 | 0.869 | |
| More-affected N2 | ||||||
| Correlation | 0.078 | 0.178 | 0.121 | -0.046 | 0.141 | |
| Significance | 0.599 | 0.225 | 0.412 | 0.755 | 0.341 | |
| More-affected combined N1 and N2 | ||||||
| Correlation | 0.458 | 0.324 | 0.065 | 0.025 | 0.031 | |
| Significance | 0.001* | 0.024* | 0.663 | 0.869 | 0.834 | |
| More-affected whole SNpc | ||||||
| Correlation | 0.304 | 0.332 | 0.162 | 0.059 | 0.134 | |
| Significance | 0.036* | 0.021* | 0.272 | 0.690 | 0.363 | |
*p<0.05, statistical significance.
CR, contrast ratio; NM-MRI, neuromelanin-sensitive magnetic resonance imaging; N1, nigrosome 1; N2, nigrosome 2; SNpc, substantia nigra pars compacta; SUVR, standardized uptake value ratio; 18F-FP-CIT PET, N-3-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane positron-emission tomography.